Investing in foreign stocks presents a unique opportunity for diversification and growth in an investment portfolio. One ...

On May 7, Calliditas Therapeutics (spons ADRs) will report earnings from Q1. Analysts predict Calliditas Therapeutics (spons ADRs) will release losses per share of $0.162. Follow Calliditas ...

On May 6, BioNTech (ADRs) will be reporting earnings Q1. Wall Street analysts expect BioNTech (ADRs) will be reporting losses per share of €1.243. Go here to follow BioNTech (ADRs) stock price in real ...

Key Takeaways Li Auto ADRs jumped in premarket trading Monday as the electric vehicle (EV) maker said orders for its newest ...

Understanding the mechanisms underpinning ADRs may help mitigate risk by identifying individuals at risk of developing ADRs for a given drug and to provide alternate treatment with a more ...

The American Depository Receipts of Nio, a Shanghai-based electric vehicle maker, just popped 20%, according to CNBC. Yet the ...

FY24 has been a roller coaster ride for Indias three mega IT companies. These are TCS, Infosys, and Wipro. All three have of ...

AstraZeneca's sales of cancer drugs helped the pharmaceutical firm beat first-quarter estimates for earnings and revenue.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Wipro's American Depository Receipts (ADRs) surged over 4% on Friday to hit the day's high of $5.37 on the New York Stock ...

It should be noted that off-target binding of the drug could lead to ADRs and may not be related to the same level of exposure that is responsible for on-target efficacy. Thus, an understanding of ...